Chase AIPricingFAQs
Display currency
Loading news…

Intervacc

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Hägersten, Stockholms Lan, Sweden Founded 2001 11-50 employees For Profit

Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5
Patents
12
5 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
12
Trademarks
5
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Company Info

Founded
2001
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
News articles
55
HQ
Hägersten, Stockholms Lan, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.3
Trend (30d)
-1.4
Trend (90d)
-1.2
Last leadership hire
Feb 5, 2026

Key People at Intervacc

Chief Executive Officer and Group CEO
5
professional contacts at Intervacc
Contact execs at Intervacc

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Intervacc

Loading news…

FAQs about Intervacc

People who checked this page also checked these

Browse the full Acquirezy directory.
Intervacc - Company Profile, Full Acquisitions List, Funding and Investments